家族史引导的身体活动预防心血管疾病。

IF 4.5 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Ana Polo-López, Joaquín Calatayud, Laura López-Bueno, Rodrigo Núñez-Cortés, Lars Louis Andersen, Rubén López-Bueno
{"title":"家族史引导的身体活动预防心血管疾病。","authors":"Ana Polo-López, Joaquín Calatayud, Laura López-Bueno, Rodrigo Núñez-Cortés, Lars Louis Andersen, Rubén López-Bueno","doi":"10.1016/j.amepre.2025.108080","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>It remains unclear if individuals with a family history of cardiovascular disease (CVD) can achieve similar CVD incidence reductions through moderate-to-vigorous physical activity (MVPA) as those without a family history. The aim of the study was to investigate the importance of familial CVD history on the association of MVPA with CVD risk.</p><p><strong>Methods: </strong>A prospective cohort from the UK Biobank who completed one week of accelerometer-based MVPA measurements from June 1, 2013, to December 23, 2015 was analyzed. The exposures were the different doses of MVPA derived from accelerometry. The main outcomes and measures were the dose-response associations between moderate-to-vigorous MVPA and incident CVD in individuals with and without a family history of CVD.</p><p><strong>Results: </strong>74,715 individuals (mean age 55.2 years) were examined. The median follow-up time was 7.9 years. The dose-response association between MVPA and incident CVD among individuals with family history of CVD showed significant risk reductions within the range of 10-1,555 weekly minutes (reference: 0 MVPA minutes). The optimal risk reduction (i.e., nadir of the curve) was identified at 555 weekly minutes of MVPA (HR, 0.72 [95% CI, 0.64-0.81]). The dose-response associations between MVPA and incident CVD among individuals with no family history of CVD showed significant risk reductions within the range of 220-555 weekly minutes. The optimal risk reduction was identified at 445 weekly minutes of MVPA (HR, 0.80 [95% CI, 0.65-0.99]).</p><p><strong>Conclusions: </strong>Physical activity guidelines should account for familial CVD history, as those with a family history may achieve greater risk reductions.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108080"},"PeriodicalIF":4.5000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Family History-Guided Physical Activity for Cardiovascular Disease Prevention.\",\"authors\":\"Ana Polo-López, Joaquín Calatayud, Laura López-Bueno, Rodrigo Núñez-Cortés, Lars Louis Andersen, Rubén López-Bueno\",\"doi\":\"10.1016/j.amepre.2025.108080\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>It remains unclear if individuals with a family history of cardiovascular disease (CVD) can achieve similar CVD incidence reductions through moderate-to-vigorous physical activity (MVPA) as those without a family history. The aim of the study was to investigate the importance of familial CVD history on the association of MVPA with CVD risk.</p><p><strong>Methods: </strong>A prospective cohort from the UK Biobank who completed one week of accelerometer-based MVPA measurements from June 1, 2013, to December 23, 2015 was analyzed. The exposures were the different doses of MVPA derived from accelerometry. The main outcomes and measures were the dose-response associations between moderate-to-vigorous MVPA and incident CVD in individuals with and without a family history of CVD.</p><p><strong>Results: </strong>74,715 individuals (mean age 55.2 years) were examined. The median follow-up time was 7.9 years. The dose-response association between MVPA and incident CVD among individuals with family history of CVD showed significant risk reductions within the range of 10-1,555 weekly minutes (reference: 0 MVPA minutes). The optimal risk reduction (i.e., nadir of the curve) was identified at 555 weekly minutes of MVPA (HR, 0.72 [95% CI, 0.64-0.81]). The dose-response associations between MVPA and incident CVD among individuals with no family history of CVD showed significant risk reductions within the range of 220-555 weekly minutes. The optimal risk reduction was identified at 445 weekly minutes of MVPA (HR, 0.80 [95% CI, 0.65-0.99]).</p><p><strong>Conclusions: </strong>Physical activity guidelines should account for familial CVD history, as those with a family history may achieve greater risk reductions.</p>\",\"PeriodicalId\":50805,\"journal\":{\"name\":\"American Journal of Preventive Medicine\",\"volume\":\" \",\"pages\":\"108080\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-09-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Preventive Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.amepre.2025.108080\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Preventive Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amepre.2025.108080","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

目前尚不清楚有心血管疾病家族史(CVD)的个体是否可以通过中等到高强度的身体活动(MVPA)达到与没有家族史的个体相似的CVD发病率降低。本研究的目的是探讨家族性心血管疾病史对MVPA与心血管疾病风险之间关系的重要性。方法:对2013年6月1日至2015年12月23日完成为期一周的加速度计MVPA测量的英国生物银行(UK Biobank)前瞻性队列进行分析。暴露是由加速度计得出的不同剂量的MVPA。主要结果和测量是在有或没有心血管疾病家族史的个体中,中度至重度MVPA与心血管疾病发生率之间的剂量反应关系。结果:共检查74,715例(平均年龄55.2岁)。中位随访时间为7.9年。在有CVD家族史的个体中,MVPA与CVD事件之间的剂量-反应关联显示,在10- 1555周分钟(参考:0 MVPA分钟)范围内,风险显著降低。最佳风险降低(即曲线最低点)被确定为555周MVPA分钟(HR, 0.72 [95% CI, 0.64-0.81])。在没有CVD家族史的个体中,MVPA与CVD发生率之间的剂量-反应相关性显示,在220-555分钟的每周时间范围内,风险显著降低。最佳风险降低确定为每周445分钟的MVPA (HR, 0.80 [95% CI, 0.65-0.99])。结论:体育活动指南应考虑家族性心血管疾病史,因为有家族病史的人可能会获得更大的风险降低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Family History-Guided Physical Activity for Cardiovascular Disease Prevention.

Introduction: It remains unclear if individuals with a family history of cardiovascular disease (CVD) can achieve similar CVD incidence reductions through moderate-to-vigorous physical activity (MVPA) as those without a family history. The aim of the study was to investigate the importance of familial CVD history on the association of MVPA with CVD risk.

Methods: A prospective cohort from the UK Biobank who completed one week of accelerometer-based MVPA measurements from June 1, 2013, to December 23, 2015 was analyzed. The exposures were the different doses of MVPA derived from accelerometry. The main outcomes and measures were the dose-response associations between moderate-to-vigorous MVPA and incident CVD in individuals with and without a family history of CVD.

Results: 74,715 individuals (mean age 55.2 years) were examined. The median follow-up time was 7.9 years. The dose-response association between MVPA and incident CVD among individuals with family history of CVD showed significant risk reductions within the range of 10-1,555 weekly minutes (reference: 0 MVPA minutes). The optimal risk reduction (i.e., nadir of the curve) was identified at 555 weekly minutes of MVPA (HR, 0.72 [95% CI, 0.64-0.81]). The dose-response associations between MVPA and incident CVD among individuals with no family history of CVD showed significant risk reductions within the range of 220-555 weekly minutes. The optimal risk reduction was identified at 445 weekly minutes of MVPA (HR, 0.80 [95% CI, 0.65-0.99]).

Conclusions: Physical activity guidelines should account for familial CVD history, as those with a family history may achieve greater risk reductions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
American Journal of Preventive Medicine
American Journal of Preventive Medicine 医学-公共卫生、环境卫生与职业卫生
CiteScore
8.60
自引率
1.80%
发文量
395
审稿时长
32 days
期刊介绍: The American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health. Of particular emphasis are papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women''s health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and substance use disorders. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. Papers on health services research pertinent to prevention and public health are also published. The journal also publishes official policy statements from the two co-sponsoring organizations, review articles, media reviews, and editorials. Finally, the journal periodically publishes supplements and special theme issues devoted to areas of current interest to the prevention community.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信